Cargando…
Identification of Gene Biomarkers for Tigilanol Tiglate Content in Fontainea picrosperma
Tigilanol tiglate (EBC-46) is a small-molecule natural product under development for the treatment of cancers in humans and companion animals. The drug is currently produced by purification from the Australian rainforest tree Fontainea picrosperma (Euphorbiaceae). As part of a selective-breeding pro...
Autores principales: | Mitu, Shahida A, Stewart, Praphaporn, Tran, Trong D, Reddell, Paul W, Cummins, Scott F, Ogbourne, Steven M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9268252/ https://www.ncbi.nlm.nih.gov/pubmed/35807225 http://dx.doi.org/10.3390/molecules27133980 |
Ejemplares similares
-
Floral attraction and flower visitors of a subcanopy, tropical rainforest tree, Fontainea picrosperma
por: Grant, Elektra L., et al.
Publicado: (2021) -
The P450 multigene family of Fontainea and insights into diterpenoid synthesis
por: Mitu, Shahida A., et al.
Publicado: (2021) -
Cryptic Epoxytiglianes
from the Kernels of the Blushwood
Tree (Fontainea picrosperma)
por: Chianese, Giuseppina, et al.
Publicado: (2022) -
Use of the Intratumoural Anticancer Drug Tigilanol Tiglate in Two Horses
por: De Ridder, Thomas, et al.
Publicado: (2020) -
Population genetic analysis of a medicinally significant Australian rainforest tree, Fontainea picrosperma C.T. White (Euphorbiaceae): biogeographic patterns and implications for species domestication and plantation establishment
por: Lamont, R. W., et al.
Publicado: (2016)